Literature DB >> 11848469

Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.

E Mahdy1, Y Pan, N Wang, P U Malmström, P Ekman, U Bergerheim.   

Abstract

Chromosome 8 aberration and c-myc amplification have been suggested as playing important roles in the development of different human cancers. Using fluorescence in situ hybridization (FISH), chromosome 8 polysomy and c-myc amplification can be detected in cells from bladder cancer. We investigated the correlation of chromosome 8 polysomy, c-myc gene alteration and p53 deletion with histopathological parameters. Twenty-four tumors obtained from patients with bladder cancer were analyzed by interphase cytogenetics using FISH with chromosome 8 and 17 centromere probes together with an YAC clone covering the c-myc locus and three cosmid DNA probes covering the p53 locus. Chromosome 8 polysomy was found in 12 tumors. The average copy number of chromosome 8 centromere signals were significantly higher in high grade and stage, cancers. Also the c-myc copy gain and p53 deletion were significantly correlated with grade as well as stage (p<0.05, in both cases). Both polysomy 8 and c-myc copy gain were significantly correlated with p53 deletions (p<0.01) and DNA ploidy (p<0.001). On the contrary there was no significant correlation between c-myc protein over-expression and c-myc gene amplification. These results may indicate that alteration of chromosomal regions on 8q and 17p, including c-myc and p53 genes, may be linked to progression of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11848469

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.

Authors:  Yuanjun Jiang; Yushuang Han; Chaonan Sun; Chuyang Han; Ning Han; Weiwei Zhi; Qiao Qiao
Journal:  Tumour Biol       Date:  2015-12-29

2.  LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.

Authors:  R Matsuda; H Enokida; T Chiyomaru; N Kikkawa; T Sugimoto; K Kawakami; S Tatarano; H Yoshino; K Toki; Y Uchida; K Kawahara; K Nishiyama; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

3.  Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder.

Authors:  Francesco Massari; Emilio Bria; Chiara Ciccarese; Enrico Munari; Alessandra Modena; Valentina Zambonin; Isabella Sperduti; Walter Artibani; Liang Cheng; Guido Martignoni; Giampaolo Tortora; Matteo Brunelli
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

4.  c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma.

Authors:  Pie-Che Chen; Chih-Chia Yu; Wen-Yu Huang; Wan-Hong Huang; Yu-Ming Chuang; Ru-Inn Lin; Jora M J Lin; Hon-Yi Lin; Yeong-Chin Jou; Cheng-Huang Shen; Michael W Y Chan
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

5.  Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.

Authors:  Amira Emad Elwy; Tarek Mohamed Elsaba; Ahmed Refaat Abd Elzaher; Mahmoud Ismail Nassar
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

6.  Targeted therapies in the management of metastatic bladder cancer.

Authors:  Matteo Fassan; Edouard J Trabulsi; Leonard G Gomella; Raffaele Baffa
Journal:  Biologics       Date:  2007-12

7.  CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.

Authors:  Yu-Hui Wang; Wen-Jeng Wu; Wei-Jan Wang; Hsuan-Ying Huang; Wei-Ming Li; Bi-Wen Yeh; Ting-Feng Wu; Yow-Ling Shiue; Jim Jinn-Chyuan Sheu; Ju-Ming Wang; Chien-Feng Li
Journal:  Oncotarget       Date:  2015-10-13

8.  Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.

Authors:  Ti-Chun Chan; Yi-Ting Chen; Kien Thiam Tan; Chia-Ling Wu; Wen-Jeng Wu; Wei-Ming Li; Ju-Ming Wang; Yow-Ling Shiue; Chien-Feng Li
Journal:  Clin Transl Med       Date:  2021-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.